These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23446490)

  • 21. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic algicidal effect and mechanism of two diketopiperazines produced by Chryseobacterium sp. strain GLY-1106 on the harmful bloom-forming Microcystis aeruginosa.
    Guo X; Liu X; Pan J; Yang H
    Sci Rep; 2015 Oct; 5():14720. PubMed ID: 26423356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
    Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
    Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
    Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
    Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-candidal activity of Satureja khuzistanica ethanol extract against clinical isolates of C. albicans.
    Mahboubi M; Kazempour N
    J Mycol Med; 2016 Mar; 26(1):e6-10. PubMed ID: 26849903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between amphotericin B and nitroimidazoles against Candida albicans.
    Cury AE; Hirschfeld MP
    Mycoses; 1997 Oct; 40(5-6):187-92. PubMed ID: 9476486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three bioactive cyclic dipeptides from the Bacillus sp. N strain associated with entomopathogenic nematode.
    Nishanth SK; Nambisan B; Dileep C
    Peptides; 2014 Mar; 53():59-69. PubMed ID: 24291459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic action of clotrimazole and certain anionic surfactants may be due to ion pair formation.
    Pedersen M
    Acta Pharm Nord; 1990; 2(6):367-70. PubMed ID: 2095795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synergistic effect of azole antimycotics (clotrimazole and fluconazole) and natural substances].
    Kuruc M; Čonková E
    Ceska Slov Farm; 2017; 66(4):164-167. PubMed ID: 29351379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synergistic effect of clotrimazole and hexamidinediisethionate against Candida albicans].
    Früh H
    Mykosen; 1985 Oct; 28(10):495-500. PubMed ID: 3906390
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel synergism of two antifungal agents, copiamycin and imidazole.
    Uno J; Shigematsu ML; Arai T
    Antimicrob Agents Chemother; 1983 Oct; 24(4):552-9. PubMed ID: 6316846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
    Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
    Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effect of amphotericin B and flucytosine on hyphal growth of Candida albicans estimated at a single hypha level.
    Oh KB; Yang HC; Matsuoka H; Yamamoto A; Kurata H
    J Med Vet Mycol; 1995; 33(3):191-5. PubMed ID: 7666300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
    Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
    J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.